Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

Paolo Milani; Stefan Schönland; Giovanni Palladini; Christoph Kimmich; Marco Basset; Francesca Russo; Andrea Foli; Stefano Perlini; Tilmann Bochtler; Anthony D. Ho; Giampaolo Merlini; Ute Hegenbart

doi:10.1080/13506129.2017.1292240

Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

Paolo Milani, Stefan Schönland, Giovanni Palladini, Christoph Kimmich, Marco Basset, Francesca Russo, Andrea Foli, Stefano Perlini, Tilmann Bochtler, Anthony D. Ho, Giampaolo Merlini, Ute Hegenbart

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	56-57
Number of pages	2
Journal	Amyloid
Volume	24
DOIs	https://doi.org/10.1080/13506129.2017.1292240
Publication status	Published - Mar 16 2017

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1080/13506129.2017.1292240

Cite this

Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis. / Milani, Paolo; Schönland, Stefan; Palladini, Giovanni; Kimmich, Christoph; Basset, Marco; Russo, Francesca; Foli, Andrea ; Perlini, Stefano; Bochtler, Tilmann; Ho, Anthony D.; Merlini, Giampaolo; Hegenbart, Ute.

In: Amyloid, Vol. 24, 16.03.2017, p. 56-57.

Research output: Contribution to journal › Letter › peer-review

Milani, Paolo ; Schönland, Stefan ; Palladini, Giovanni ; Kimmich, Christoph ; Basset, Marco ; Russo, Francesca ; Foli, Andrea ; Perlini, Stefano ; Bochtler, Tilmann ; Ho, Anthony D. ; Merlini, Giampaolo ; Hegenbart, Ute. / Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis. In: Amyloid. 2017 ; Vol. 24. pp. 56-57.

@article{4f992cb1a35f4ca5adac586342ad9b9c,

title = "Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis",

author = "Paolo Milani and Stefan Sch{\"o}nland and Giovanni Palladini and Christoph Kimmich and Marco Basset and Francesca Russo and Andrea Foli and Stefano Perlini and Tilmann Bochtler and Ho, {Anthony D.} and Giampaolo Merlini and Ute Hegenbart",

year = "2017",

month = mar,

day = "16",

doi = "10.1080/13506129.2017.1292240",

language = "English",

volume = "24",

pages = "56--57",

journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",

issn = "1350-6129",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

AU - Milani, Paolo

AU - Schönland, Stefan

AU - Palladini, Giovanni

AU - Kimmich, Christoph

AU - Basset, Marco

AU - Russo, Francesca

AU - Foli, Andrea

AU - Perlini, Stefano

AU - Bochtler, Tilmann

AU - Ho, Anthony D.

AU - Merlini, Giampaolo

AU - Hegenbart, Ute

PY - 2017/3/16

Y1 - 2017/3/16

UR - http://www.scopus.com/inward/record.url?scp=85018756617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018756617&partnerID=8YFLogxK

U2 - 10.1080/13506129.2017.1292240

DO - 10.1080/13506129.2017.1292240

M3 - Letter

AN - SCOPUS:85018756617

VL - 24

SP - 56

EP - 57

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

SN - 1350-6129

ER -

Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this